| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine
|
Qian, Ping
|
|
2004
|
22 |
17-18 |
p. 2129-2136
8 p.
|
article
|
| 2 |
A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model
|
Horimoto, Taisuke
|
|
2004
|
22 |
17-18 |
p. 2244-2247
4 p.
|
article
|
| 3 |
Assessing the impact of wastage on pediatric vaccine immunization formulary costs using a vaccine selection algorithm
|
Jacobson, Sheldon H
|
|
2004
|
22 |
17-18 |
p. 2307-2315
9 p.
|
article
|
| 4 |
Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens
|
Francois, Achille
|
|
2004
|
22 |
17-18 |
p. 2351-2360
10 p.
|
article
|
| 5 |
Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999–2000
|
Gil, A
|
|
2004
|
22 |
17-18 |
p. 2221-2225
5 p.
|
article
|
| 6 |
DNA immunization with plasmids expressing hCGβ-chimeras
|
Terrazzini, Nadia
|
|
2004
|
22 |
17-18 |
p. 2146-2153
8 p.
|
article
|
| 7 |
Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands
|
Kroneman, Madelon W.
|
|
2004
|
22 |
17-18 |
p. 2163-2170
8 p.
|
article
|
| 8 |
Editorial Board/Aims and Scope
|
|
|
2004
|
22 |
17-18 |
p. IFC-
1 p.
|
article
|
| 9 |
Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine
|
Borja-Cabrera, Gulnara Patricia
|
|
2004
|
22 |
17-18 |
p. 2234-2243
10 p.
|
article
|
| 10 |
Effectiveness of the linkage of child care and maternity payments to childhood immunisation
|
Lawrence, Glenda L.
|
|
2004
|
22 |
17-18 |
p. 2345-2350
6 p.
|
article
|
| 11 |
Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus
|
Moreau, Isabelle A.
|
|
2004
|
22 |
17-18 |
p. 2328-2333
6 p.
|
article
|
| 12 |
Evaluation of a recombinant salivary gland protein (thrombostasin) as a vaccine candidate to disrupt blood-feeding by horn flies
|
Cupp, Mary S
|
|
2004
|
22 |
17-18 |
p. 2285-2297
13 p.
|
article
|
| 13 |
Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase
|
Stewart-Tull, Duncan E.S
|
|
2004
|
22 |
17-18 |
p. 2137-2145
9 p.
|
article
|
| 14 |
Family physician perspectives on barriers to childhood immunisation
|
Petousis-Harris, Helen
|
|
2004
|
22 |
17-18 |
p. 2340-2344
5 p.
|
article
|
| 15 |
Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection
|
Locher, Christopher P
|
|
2004
|
22 |
17-18 |
p. 2261-2272
12 p.
|
article
|
| 16 |
Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory
|
Bakke, Hilde
|
|
2004
|
22 |
17-18 |
p. 2278-2284
7 p.
|
article
|
| 17 |
Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease
|
Norheim, Gunnstein
|
|
2004
|
22 |
17-18 |
p. 2171-2180
10 p.
|
article
|
| 18 |
Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers
|
Metzger, W.G
|
|
2004
|
22 |
17-18 |
p. 2273-2277
5 p.
|
article
|
| 19 |
Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients
|
Vogtländer, N.P.J
|
|
2004
|
22 |
17-18 |
p. 2199-2201
3 p.
|
article
|
| 20 |
Liposome adjuvants prepared from the total polar lipids of Haloferax volcanii, Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses
|
Sprott, G.D
|
|
2004
|
22 |
17-18 |
p. 2154-2162
9 p.
|
article
|
| 21 |
Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture
|
Genzel, Y
|
|
2004
|
22 |
17-18 |
p. 2202-2208
7 p.
|
article
|
| 22 |
Moderate exercise improves antibody response to influenza immunization in older adults
|
Kohut, Marian L
|
|
2004
|
22 |
17-18 |
p. 2298-2306
9 p.
|
article
|
| 23 |
Pneumococcal vaccines: an update on current strategies
|
Bogaert, D
|
|
2004
|
22 |
17-18 |
p. 2209-2220
12 p.
|
article
|
| 24 |
Pressure-inactivated FMDV: a potential vaccine
|
Ishimaru, Daniella
|
|
2004
|
22 |
17-18 |
p. 2334-2339
6 p.
|
article
|
| 25 |
Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles
|
Harcourt, Jennifer L
|
|
2004
|
22 |
17-18 |
p. 2248-2260
13 p.
|
article
|
| 26 |
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants
|
Zepp, F
|
|
2004
|
22 |
17-18 |
p. 2226-2233
8 p.
|
article
|
| 27 |
Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960
|
Gzyl, Anna
|
|
2004
|
22 |
17-18 |
p. 2122-2128
7 p.
|
article
|
| 28 |
Sub-compartmentalization of the gastrointestinal (GI) immune system determined with microbeads that differ in release properties
|
Cronkhite, Richard Ivan
|
|
2004
|
22 |
17-18 |
p. 2106-2115
10 p.
|
article
|
| 29 |
Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen
|
Shen, Hua
|
|
2004
|
22 |
17-18 |
p. 2116-2121
6 p.
|
article
|
| 30 |
The apoptotic and necrotic effects of tomatine adjuvant
|
Yang, Ya-Wun
|
|
2004
|
22 |
17-18 |
p. 2316-2327
12 p.
|
article
|
| 31 |
The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over
|
Kelly, Heath
|
|
2004
|
22 |
17-18 |
p. 2192-2198
7 p.
|
article
|
| 32 |
4th Meeting on novel adjuvants currently in/close to human clinical testing
|
Pink, J.Richard
|
|
2004
|
22 |
17-18 |
p. 2097-2102
6 p.
|
article
|
| 33 |
Using computer simulations to compare pertussis vaccination strategies in Australia
|
Hethcote, Herbert W
|
|
2004
|
22 |
17-18 |
p. 2181-2191
11 p.
|
article
|
| 34 |
Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®
|
Kitchener, Scott
|
|
2004
|
22 |
17-18 |
p. 2103-2105
3 p.
|
article
|
Journal description